Clinical Trial Update: Safety, Tolerability and Effects of L-Arginine in Boys With Dystrophinopathy on Corticosteroids [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety, tolerability, and effects of L-Arginine in boys with dystrophinopathy on corticosteroids, including Duchenne and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Becker Muscular Dystrophy
• Duchenne Muscular Dystrophy

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Dystrophinopathy, Duchenne Muscular Dystrophy | Phase 1 | Status: COMPLETED